BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Nimer A, M P, D G, Y B, G S. Clinical implication of VEGF serum levels in cirrhotic patients with or without portal hypertension. World J Gastroenterol 1999; 5(4): 296-300 [PMID: 11819451 DOI: 10.3748/wjg.v5.i4.296]
URL: https://www.wjgnet.com/1007-9327/full/v5/i4/296.htm
Number Citing Articles
1
Eugenio Gaudio, Barbara Barbaro, Domenico Alvaro, Shannon Glaser, Heather Francis, Antonio Franchitto, Paolo Onori, Yoshiyuki Ueno, Marco Marzioni, Giammarco Fava, Julie Venter, Ramona Reichenbach, Ryun Summers, Gianfranco Alpini. Administration of r-VEGF-A prevents hepatic artery ligation-induced bile duct damage in bile duct ligated ratsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2006; 291(2): G307 doi: 10.1152/ajpgi.00507.2005
2
Alexandr S. Ivanov, Irina V. Garmasch, Olga S. Arisheva, Mariya A. Markova, Anna S. Melnik, Natalya N. Terebilina, Valeria Yu. Baronets, Daniil I. Peregud, Ekaterina V. Tarasenko, Zhanna D. Kobalava. Association of SNPs in the Promoter Regions of VEGF (rs699947 и rs2010963), ICAM1 (rs281437) and ET-1 (rs1800541) with Serum Levels of Related Proteins and Alcoholic Liver Cirrhosis RiskAnnals of the Russian academy of medical sciences 2018; 73(6): 368 doi: 10.15690/vramn1059
3
Muttiah Barathan, Behnaz Riazalhosseini, Thevambiga Iyadorai, Kumutha Malar Vellasamy, Jamuna Vadivelu, Li-Yen Chang, Ahmad Khusairy Zulpa, Marie Larsson, Esaki M. Shankar, Rosmawati Mohamed. Comparative expression of pro-inflammatory and apoptotic biosignatures in chronic HBV-infected patients with and without liver cirrhosisMicrobial Pathogenesis 2021; 161: 105231 doi: 10.1016/j.micpath.2021.105231